Paradoxical effects of streptozotocin-induced diabetes on endothelial dysfunction in stroke-prone spontaneously hypertensive rats

Journal of Physiology

Volumn 589, Issue 21, 2011, Pages 5153-5165

  Zhong, Mei Fang ^a   Shen, Wei Li ^a   Wang, Jian ^a   Yang, Jie ^a   Yuan, Wen Jun ^b   He, Jin ^a   Wu, Ping Ping ^a   Wang, Yuan ^a   Zhang, Lan ^a   Higashino, Hideaki ^c   Chen, Hong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; HEAT SHOCK PROTEIN 110; HEAT SHOCK PROTEIN 32; HEAT SHOCK PROTEIN 90; HEME OXYGENASE 1; HEME OXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; MANNITOL; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; HYPERGLYCEMIA; HYPEROSMOLARITY; HYPERTENSION; IN VITRO STUDY; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; VASCULAR ENDOTHELIUM; VASODILATATION; WESTERN BLOTTING;

ACETYLCHOLINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA, THORACIC; DIABETES MELLITUS, EXPERIMENTAL; HEME OXYGENASE (DECYCLIZING); HYPERGLYCEMIA; HYPERTENSION; MACROPHAGES; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITROPRUSSIDE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REACTIVE OXYGEN SPECIES; STREPTOZOCIN; TUNICA INTIMA; VASODILATION; VASODILATOR AGENTS;

EID: 80055016811     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.213686     Document Type: Article

References (48)

1. Abraham NG & Kappas A (2008). Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60, 79-127.
2. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG & Friedewald WT (2008). Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358, 2545-2559.
3. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R & Travert F (2008). Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358, 2560-2572.
4. Alexander CM, Landsman PB, Teutsch SM & Haffner SM (2003). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52, 1210-1214.
5. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W & Sowers J (2000). Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 36, 646-661.
6. Bohlen HG (1998). Mechanism of increased vessel wall nitric oxide concentrations during intestinal absorption. Am J Physiol Heart Circ Physiol 275, H542-H550.
7. Bohlen HG (2004). Mechanism for early microvascular injury in obesity and type II diabetes. Curr Hypertens Rep 6, 60-65.
8. Burger D, Lei M, Geoghegan-Morphet N, Lu X, Xenocostas A & Feng Q (2006). Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Cardiovasc Res 72, 51-59.
9. Chen H, Higashino H, Kamenov ZA, Azuma M, Lee WH, Yang XQ, Zhou DJ & Yuan WJ (2003a). Preserved postischemic heart function in sucrose-fed type 2 diabetic OLETF rats. Life Sci 72, 2839-2851.
10. Chen H, Shen WL, Wang XH, Chen HZ, Gu JZ, Fu J, Ni YF, Gao PJ, Zhu DL & Higashino H (2006). Paradoxically enhanced heart tolerance to ischaemia in type 1 diabetes and role of increased osmolarity. Clin Exp Pharmacol Physiol 33, 910-916.
11. Chen H, Zhong MF & Shen WL (2009). Endothelium-dependent vasodilation in aorta from stroke-prone spontaneously hypertensive rats made hyperglycemia with streptozocin (abstract). J Vasc Res 46(Suppl. 1), 155, doi:.
12. Chen LB, Liu Tao, Wu JX, Chen XF, Wang L, Fan CL, Gao PJ, Higashino H, Lee WH, Yuan WJ & Chen H (2003b). Hypertonic perfusion reduced myocardial injury during subsequent ischemia and reperfusion in normal and hypertensive rats. Acta Pharmacol Sin 24, 1077-1082.
13. Chen YC, Du Z, Zhong MF, Sun HX, Yang J, Teng L, Nakamura K, Tabuchi M, Higashino H, Gu JZ & Chen H (2011). Changes of endothelium-dependent vasodilation in aortae from obese and non-obese type 2 diabetic rats and roles of hyperglycemia/hyperosmolarity. Chin J Hypertens 19, 529-537.
14. Chu LM, Osipov RM, Robich MP, Feng J, Oyamada S, Bianchi C & Sellke FW (2010). Is hyperglycaemia bad for the heart during acute ischemia? J Thorac Cardiovasc Surg 140, 1345-1352.
15. Cosentino F, Hishikawa K, Katusic ZS & Lüscher TF (1997). High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96, 25-28.
16. Drummond GB (2009). Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol 587, 713-719.
17. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD & VADT Investigators (2009). Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360, 129-139.
18. Gao L & Mann GE (2009). Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res 82, 9-20.
19. Gerstein HC, Pogue J, Mann JF, Lonn E, Dagenais GR, McQueen M, Yusuf S & HOPE investigators (2005). The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia 48, 1749-1755.
20. He M, Siow RC, Sugden D, Gao L, Cheng X & Mann GE (2011). Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: a role for Nrf2 in vascular protection in diabetes. Nutr Metab Cardiovasc Dis 21, 277-285.
21. Heiss EH, Schachner D, Werner ER & Dirsch VM (2009). Active NF-E2-related factor (Nrf2) contributes to keep endothelial NO synthase (eNOS) in the coupled state: role of reactive oxygen species (ROS), eNOS, and heme oxygenase (HO-1) levels. J Biol Chem 284, 31579-31586.
22. Holman RR, Paul SK, Bethel MA, Matthews DR & Neil HA (2008). 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359, 1577-1589.
23. Iori E, Pagnin E, Gallo A, Calò L, Murphy E, Ostuni F, Fadini GP & Avogaro A (2008). Heme oxygenase-1 is an important modulator in limiting glucose-induced apoptosis in human umbilical vein endothelial cells. Life Sci 82, 383-392.
24. Jackson R, Lawes CM, Bennett DA, Milne RJ & Rodgers A (2005). Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 365, 434-441.
25. Jia SJ, Jiang DJ, Hu CP, Zhang XH, Deng HW & Li YJ (2006). Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells. Vascul Pharmacol 44, 143-148.
26. Kasai T, Miyauchi K, Kurata T, Okazaki S, Kajimoto K, Kubota N & Daida H (2008). Impact of metabolic syndrome among patients with and without diabetes mellitus on long-term outcomes after percutaneous coronary intervention. Hypertens Res 31, 235-241.
27. Liu Y, Thornton JD, Cohen MV, Downey JM & Schaffer SW (1993). Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation 88, 1273-1278.
28. MacKenzie A, Cooper EJ & Dowell FJ (2008). Differential effects of glucose on agonist-induced relaxations in human mesenteric and subcutaneous arteries. Br J Pharmacol 153, 480-487.
29. Matsumoto T, Kakamia M, Noguchi E, Kobayashi T & Kamata K (2007). Imbalance between endothelium-derived relaxing and contracting factors in mesenteric arteries from aged OLETF rats, a model of Type 2 diabetes. Am J Physiol Heart Circ Physiol 293, H1480-H1490.
30. Mazzone T (2010). Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data. Circulation 122, 2201-2211.
31. Molitch ME, Steffes M, Sun W, Rutledge B, Cleary P, de Boer IH, Zinman B & Lachin J; Epidemiology of Diabetes Interventions and Complications Study Group (2010). Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care 33, 1536-1543.
32. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P & Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group (2005). Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353, 2643-2653.
33. Pritchard KA Jr, Ackerman AW, Gross ER, Stepp DW, Shi Y, Fontana JT, Baker JE & Sessa WC (2001). Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem 276, 17621-17624.
34. Qiao CZ, Zhang N, Zhong MF, Bao YY, Wu GZ, Zhang C & Chen H (2010). Isolated aortic vessel function in non-obese type 2 diabetic Goto-Kakizaki rats at different ages. Chin J Hypertens 18, 474-480.
35. Ravingerova T, Neckar J, Kolar F, Stetka R, Volkovova K, Ziegelhöffer A & Styk J (2001). Ventricular arrhythmias following coronary artery occlusion in rats: is the diabetic heart less or more sensitive to ischaemia? Basic Res Cardiol 96, 160-168.
36. Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S & Sattar N (2009). Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 373, 1765-1772.
37. Reaven GM (1988). Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595-1607.
38. Ricci C, Jong CJ & Schaffer SW (2008). Proapoptotic and antiapoptotic effects of hyperglycemia: role of insulin signaling. Can J Physiol Pharmacol 86, 166-172.
39. Schaffer SW, Croft CB & Solodushko V (2000). Cardioprotective effect of chronic hyperglycaemia: effect on hypoxia-induced apoptosis and necrosis. Am J Physiol Heart Circ Physiol 278, H1948-1954.
40. Shen WL, Zhong MF, Ding WL, Wang J, Zheng L, Zhu P, Wang BS, Higashino H & Chen H (2008). Elevated catalase and heme oxygenase-1 may contribute to improved postischaemic cardiac function in long-term type 1 diabetes. Clin Exp Pharmacol Physiol 35, 820-826.
41. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC & Holman RR (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321, 405-412.
42. 2+ metabolism. Circ Res 62, 931-940.
43. Waller BF, Palumbo PJ, Lie JT & Roberts WC (1980). Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects. Am J Med 69, 498-506.
44. Wang LP, Chen HZ, Gao PJ, Zhu DL, Yuan WJ & Chen H (2006). Hypertonic buffer increased antioxidative activity of hypertensive rat heart during ischemia and reperfusion injury. Chin J Hypertens 14, 370-374.
45. Wang P & Chatham JC (2004). Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab 286, E725-E736.
46. Wiernsperger NF (2003). Oxidative stress as a therapeutic target in diabetes: revisiting the controversy. Diabetes Metab 29, 579-585.
47. Zani BG & Bohlen HG (2005). Sodium channels are required during in vivo sodium chloride hyperosmolarity to stimulate increase in intestinal endothelial nitric oxide production. Am J Physiol Heart Circ Physiol 288, H89-95.
48. Zhong MF, Shen WL, Tabuchi M, Nakamura K, Chen YC, Qiao CZ, He J, Yang J, Zhang C, Kamenov Z, Higashino H & Chen H (2012). Differential changes of aorta and carotid vasodilation in type 2 diabetic GK and OLETF rats-Paradoxical roles of hyperglycemia and insulin. Exp Diabetes Res 2012, doi:.